Free tool
Rare disease stocks
We cover 9 companies grouped under the Rare disease theme. The median market value in the group is $547.34M. Across the group, the median move over the past trading day is −0.53%. Price change over the past year runs from −35.9% to +30.5% across the middle 80 percent of the group, with a median of −2.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 268 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NEU.AX | Neuren Pharmaceuticals Limited | 20.59 AUD | +20.20% | +8.88% | +5.54% |
| PYC.AX | PYC Therapeutics Limited | 2.25 AUD | +38.46% | +35.95% | +74.42% |
| 4516.T | Nippon Shinyaku Co., Ltd. | 3,588.00 JPY | +1.07% | −34.41% | +19.48% |
| 006280.KS | GC Biopharma Corp. | 127,100.00 KRW | +12.28% | −19.46% | −2.60% |
| 005257.KS | GC Corp. | 16,630.00 KRW | +20.51% | −35.95% | −40.16% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | 531.00 JPY | +2.71% | −21.85% | −9.63% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | 9.36 AUD | −2.40% | −26.36% | −24.94% |
| 4599.T | StemRIM | 350.00 JPY | +21.53% | +32.08% | +14.75% |
| DXB.AX | Dimerix Limited | 0.29 AUD | +20.83% | −47.27% | −34.83% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.